- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01460823
Percutaneous Cochlear Implantation: Implementation of Technique (PCI-I)
December 15, 2014 updated by: Robert F. Labadie, Vanderbilt University
The investigators are studying a new way of doing cochlear implant surgery called "Percutaneous Cochlear Implantation".
In this surgery, instead of doing a mastoidectomy where about 30ml of bone is removed, the investigators use image-guided technology (similar to GPS systems used to guide automobile travel) to drill directly from the surface of the skull to the cochlea, removing less than 2ml of bone.
To use this technique, three markers (or anchor screws) are screwed into the bone around the ear.
Next, an x-ray of the head (called a CT scan) is taken.
Using this CT scan, a path to the inner ear (cochlea) is planned and a drill guide (Microtable) is made that mounts on the anchor screws.
A drill will be attached to the guide and used to drill a path from the surface of the skull to the inner ear (cochlea).
The implant electrode will be threaded through this path.
All of these procedures take place under general anesthesia.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-80 year old patients undergoing cochlear implantation who are able to participate in the informed consent process.
- Pre-operative CT scan of head performed as standard of care for cochlear implant work-up.
Exclusion Criteria:
- Patients with co-morbidities so severe that the potential additional operating room time is deemed to be too significant of an operative risk. This assessment is made by the local institutions pre-operative work-up.
- History of allergic reaction/intolerance of local anesthesia and/or epinephrine.
- History of allergic reaction to titanium.
- Patients with severe anatomical abnormality of the temporal bone.
- Patients with severe chronic ear disease for whom traditional mastoidectomy might offer benefit.
- Females who are pregnant.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Use of image guided surgery
|
Percutaneous Cochlear Implantation using image guided surgical techniques.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of participants who underwent successful Cochlear Implantation Via Percutaneous Method
Time Frame: Participants will be followed post operatively until their 1st follow up visit with surgeon which on average is 3 weeks after surgery.
|
A successful percutaneous cochlear implantation is one where the facial nerve was not damaged during the procedure and the surgeon did not resort back to the standard implantation method.
We will measure the percentage of participants who underwent successful cochlear implantation via the percutaneous method.
|
Participants will be followed post operatively until their 1st follow up visit with surgeon which on average is 3 weeks after surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
July 1, 2014
Study Registration Dates
First Submitted
October 24, 2011
First Submitted That Met QC Criteria
October 26, 2011
First Posted (Estimate)
October 27, 2011
Study Record Updates
Last Update Posted (Estimate)
December 16, 2014
Last Update Submitted That Met QC Criteria
December 15, 2014
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 111114
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalCompletedEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Truway Health, Inc.Enrolling by invitationSensorineural Hearing Loss | Tinnitus | Sudden Hearing Loss | Acoustic Trauma | Inner Ear Injury | Noise-Induced Hearing Loss | Vestibular DysfunctionUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Envoy Medical CorporationActive, not recruitingSensorineural Hearing Loss | Sensorineural Hearing Loss (Disorder) | Sensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound | Sensori-Neural DeafnessUnited States
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Wonju Severance Christian HospitalRecruitingHearing Loss, Sudden | Sudden Hearing Loss | Hearing Loss, Idiopathic Sudden Sensorineural | SSNHL(Sudden Sensory Neural Hearing Loss)Korea, Republic of
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Percutaneous Cochlear Implantation using image guided surgical techniques
-
Jonsson Comprehensive Cancer CenterRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
Albert Schweitzer Ziekenhuis, NetherlandsMeril Life Sciences Pvt. Ltd.; Angiocare BV, Netherlands; Salveo Medical BV,...RecruitingPercutaneous Coronary Intervention (PCI) | Coronary Arterial Disease (CAD)Netherlands
-
Assiut UniversityNot yet recruitingUpper Gastrointestinal Wall ThickeningEgypt
-
University Hospital Southampton NHS Foundation...National Institute for Health Research, United KingdomRecruitingOesophageal CancerUnited Kingdom
-
AdventHealthCompletedEsophageal CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Liver NeoplasmUnited States
-
Aarhus University Hospital SkejbyAbbottActive, not recruitingIschemic Heart Disease | Ischaemic Heart DiseaseDenmark, United Kingdom, Sweden, Finland, Germany, Belgium, Norway, Poland, Netherlands, Estonia, Ireland, Italy, Latvia
-
Peking University People's HospitalRecruitingGastrointestinal Stromal Tumor of Stomach | Submucosal Tumor of StomachChina
-
Carol Davila University of Medicine and PharmacyInstitutul Clinic Fundeni; Bucharest Emergency HospitalCompletedPancreatic AdenocarcinomaRomania